Develops small molecule drugs that modulate RNA expression to treat challenging diseases in neurology, oncology, and fibrosis.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Skyhawk Therapeutics develops novel small molecule drugs that target and modify RNA expression to address some of the world’s most challenging diseases. Using its proprietary platform, the company advances therapies across neurology, oncology, and fibrotic diseases, with a focus on conditions that have significant unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Skyhawk Therapuetics Management Team
Investors
Agent Capital
Alexandria Venture Investments
Fidelity Management and Research Co.
GreatPoint Ventures
Individuals
ShangPharma
Skyhawk Therapuetics Valuations & Financials
View real-time NPM data on Skyhawk Therapuetics stock including daily Skyhawk Therapuetics stock price estimates, valuation history, and historical share price information. Access Skyhawk Therapuetics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Skyhawk Therapuetics pricing across six independent market signals. Looking for private company due diligence data sources on Skyhawk Therapuetics? Get in touch to learn more.
Similar Companies
like Skyhawk Therapuetics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
AgVend
Climate & Sustainability
Enables agriculture retailers to digitize customer engagement and operations via branded apps, integrated tools and insights.
BioAegis Therapeutics
Healthcare & Life Sciences
Designs biologic therapies that engage the immune system to target disease with precision.
BioTrace Medical
Healthcare & Life Sciences
Supplies temporary cardiac pacing leads to improve procedural safety and support patient recovery.
Coinone
Web3 & Digital Assets
Cryptocurrency exchange platform enabling secure digital asset trading and management while advancing blockchain technology innovation.
Arch Systems
Industrials
Unlocks actionable intelligence by capturing and contextualizing machine and sensor data across production environments.
ADDX
FinTech
Digital investment platform leveraging blockchain to provide accessible private market opportunities with lower minimums.
AttoTude
AI & Machine Learning
Facilitates lightning‑fast data transfer using terahertz interconnects to improve the efficiency and speed of advanced computing systems.
Series
Media & Entertainment
Produces structured audio-visual documentation and instructional video masterclasses to support executive leadership education.
FAQ
We have answers
Skyhawk Therapuetics stock does not trade on public stock exchanges. Skyhawk Therapuetics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Skyhawk Therapuetics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Skyhawk Therapuetics Stock does not trade on public stock exchanges. In order to sell Skyhawk Therapuetics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Skyhawk Therapuetics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Skyhawk Therapuetics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Skyhawk Therapuetics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Skyhawk Therapuetics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Skyhawk Therapuetics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Skyhawk Therapuetics is a private company and has not had an IPO. There is currently no Skyhawk Therapuetics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Skyhawk Therapuetics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
